Ken Griffin Citadel Advisors
Ken Griffin founded Citadel, one of the world’s largest and most successful hedge funds. Starting his trading career from his Harvard dorm room at a young age, Griffin quickly developed a keen sense for markets and built Citadel into a global powerhouse with billions in assets under management. Known for his quantitative and technology-driven strategies, Griffin has also made headlines for significant philanthropic contributions, supporting causes in education, the arts, and public institutions. Over the years, he has earned recognition as one of the preeminent figures in modern finance.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$703M |
| 2 |
Tesla
TSLA
|
+$585M |
| 3 |
JPMorgan Chase
JPM
|
+$582M |
| 4 |
Amazon
AMZN
|
+$566M |
| 5 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$466M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$349M |
| 2 |
Home Depot
HD
|
+$334M |
| 3 |
T-Mobile US
TMUS
|
+$270M |
| 4 |
Cigna
CI
|
+$258M |
| 5 |
CDW
CDW
|
+$237M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 3.12% |
| 2 | Healthcare | 2.55% |
| 3 | Financials | 2.39% |
| 4 | Consumer Discretionary | 2.14% |
| 5 | Industrials | 1.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1851
Mirum Pharmaceuticals
MIRM
$6.14B
| $19.4M | ﹤0.01% |
925,177
+495,330
| +115% | +$11.9M |
|
1852
PUT
Franco-Nevada
FNV
$45.2B
| $19.4M | ﹤0.01% |
162,500
+27,700
| +21% | +$3.48M |
|
1853
PUT
Scotiabank
BNS
$112B
| $19.4M | ﹤0.01% |
407,400
+153,200
| +60% | +$8.76M |
|
1854
Sony
SONY
$142B
| $19.3M | ﹤0.01% |
1,510,280
+495,410
| +49% | +$7.94M |
|
|
CPUH
1855
DELISTED
Compute Health Acquisition Corp.
CPUH
| $19.3M | ﹤0.01% |
1,955,483
-328
| -0% | -$3.23K |
|
1856
DoubleVerify
DV
$2.04B
| $19.3M | ﹤0.01% |
705,513
-308,394
| -30% | -$7.95M |
|
1857
Analog Devices
ADI
$190B
| $19.3M | ﹤0.01% |
138,353
-182,741
| -57% | -$28.9M |
|
|
GRMN
1858
PUT
Garmin
GRMN
$59.8B
| $19.3M | ﹤0.01% |
240,000
+94,600
| +65% | +$8.94M |
|
1859
PUT
Kinder Morgan
KMI
$73.1B
| $19.3M | ﹤0.01% |
1,157,000
+323,300
| +39% | +$5.75M |
|
1860
CALL
Atkore
ATKR
$3.17B
| $19.2M | ﹤0.01% |
247,200
+73,400
| +42% | +$6.35M |
|
1861
PTC Therapeutics
PTCT
$5.98B
| $19.2M | ﹤0.01% |
382,985
+306,990
| +404% | +$15M |
|
1862
Air Products & Chemicals
APD
$68.8B
| $19.2M | ﹤0.01% |
82,507
-15,464
| -16% | -$3.83M |
|
1863
PUT
WIX.com
WIX
$3.1B
| $19.2M | ﹤0.01% |
245,000
+153,500
| +168% | +$10.6M |
|
1864
Tenet Healthcare
THC
$21.6B
| $19.2M | ﹤0.01% |
371,545
-1,253,542
| -77% | -$74.4M |
|
1865
CALL
Corning
GLW
$143B
| $19.2M | ﹤0.01% |
660,300
-61,000
| -8% | -$2.07M |
|
1866
PUT
Lamar Advertising Co
LAMR
$15.8B
| $19.2M | ﹤0.01% |
232,300
+196,500
| +549% | +$18.7M |
|
1867
Fulton Financial
FULT
$4.72B
| $19.2M | ﹤0.01% |
1,212,435
-285,869
| -19% | -$4.61M |
|
1868
CALL
AB InBev
BUD
$157B
| $19.1M | ﹤0.01% |
423,500
-10,300
| -2% | -$533K |
|
1869
PUT
Robinhood
HOOD
$85.9B
| $19.1M | ﹤0.01% |
1,892,600
-1,516,200
| -44% | -$14.6M |
|
1870
Castle Biosciences
CSTL
$905M
| $19.1M | ﹤0.01% |
732,655
+102,059
| +16% | +$2.86M |
|
|
FOLD
1871
DELISTED
Amicus Therapeutics
FOLD
| $19.1M | ﹤0.01% |
1,828,459
-1,899,081
| -51% | -$21.2M |
|
1872
CALL
ARK Genomic Revolution ETF
ARKG
$1.74B
| $19.1M | ﹤0.01% |
580,000
-75,000
| -11% | -$2.75M |
|
1873
Booz Allen Hamilton
BAH
$9.32B
| $19M | ﹤0.01% |
206,257
-48,856
| -19% | -$4.63M |
|
|
1874
CALL
Tenet Healthcare
THC
$21.6B
| $19M | ﹤0.01% |
368,900
+253,900
| +221% | +$15.1M |
|
|
KRTX
1875
CALL
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $19M | ﹤0.01% |
84,500
-400
| -0.5% | -$81K |
|
Similar funds
Ken Griffin's Q3 2022 Portfolio in Review
As of Q3 2022, Ken Griffin held 14,356 positions worth $439B, up 13% from $390B the previous quarter. Its ten largest holdings account for 34% of the portfolio.
Ken Griffin deployed $65.7B of net new capital in Q3 2022, opening 1,622 new positions and adding to 5,458 existing holdings. Its largest new stake was SentinelOne: 4,426,634 shares worth $113M.
By sector, the portfolio is most concentrated in Technology at 3.1% of assets, up from 2.8% a quarter earlier, followed by Healthcare and Financials.
On the sell side, the largest reduction was Meta Platforms (Facebook), an estimated $349M trimmed.
- Ken Griffin's largest Q3 2022 buy was SentinelOne: 4,426,634 shares worth $113M.
- Ken Griffin added most to Apple in Q3 2022, an estimated $703M increase.
- Ken Griffin's biggest Q3 2022 reduction was Meta Platforms (Facebook), cutting an estimated $349M.
- Ken Griffin fully exited Regions Financial in Q3 2022, selling an estimated $207M.
- Ken Griffin's ten largest holdings make up 34% of its $439B portfolio in Q3 2022.
- Ken Griffin opened 1,622 new positions and closed 1,858 in Q3 2022.
- Ken Griffin's portfolio value rose 13% quarter-over-quarter to $439B.
Based on Citadel Advisors's 13F filing for Q3 2022, filed 14 Nov 2022.